Free Trial

Immunome (IMNM) SEC Filings & 10K Form

Immunome logo
$9.53 -0.58 (-5.73%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$9.69 +0.16 (+1.67%)
As of 02/21/2025 05:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Immunome SEC Filings

DateFilerForm TypeView
02/14/2025
11:35 AM
Immunome (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
02/04/2025
4:44 PM
Immunome Aggregator, LP (Filed by)
Immunome (Subject)
Form SCHEDULE 13D/A
02/03/2025
8:01 PM
Immunome (Issuer)
SIEGALL CLAY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
4:08 PM
Immunome (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SCHEDULE 13G
01/30/2025
8:57 PM
Immunome (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
01/30/2025
3:24 PM
Immunome (Filer)
Form 424B5
01/30/2025
3:28 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2025
3:29 PM
Immunome (Filer)
Form 424B5
01/23/2025
3:01 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/25/2024
7:35 AM
Immunome (Issuer)
Lechleider Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
7:41 AM
Immunome (Issuer)
SIEGALL CLAY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
7:33 AM
Immunome (Issuer)
Tsai Philip (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
8:00 PM
Immunome (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G/A
11/14/2024
9:33 AM
Immunome (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G
11/13/2024
3:06 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
2:57 PM
Immunome (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
10:54 AM
Immunome (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/29/2024
7:05 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
Immunome (Subject)
Form SC 13G
10/08/2024
3:31 PM
Immunome (Filer)
Form S-3ASR
10/07/2024
6:14 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
6:26 PM
Immunome (Issuer)
Rosett Max (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
1:18 PM
Immunome (Subject)
Rosett Max (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
8:05 PM
Higgins Jack (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
8:07 PM
BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
2:21 PM
Higgins Jack (Reporting)
Immunome (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
4:48 PM
Immunome (Issuer)
Turner Bruce (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:51 PM
Horn Kinney (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:54 PM
Immunome (Issuer)
Stoneman Sandra G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:56 PM
Immunome (Issuer)
SIEGALL CLAY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:36 PM
Higgins Jack (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:40 PM
Immunome (Issuer)
Lechleider Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:43 PM
Immunome (Issuer)
Rosett Max (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:10 PM
Immunome (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/18/2024
7:52 PM
BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:54 PM
Immunome (Issuer)
WAGENHEIM PHILIP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:56 PM
Immunome (Issuer)
SWAIN SANDRA M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:59 PM
Immunome (Issuer)
SCHAFER CAROL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:01 PM
Boylan James P (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:05 PM
Immunome (Issuer)
Tsai Philip (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/18/2024
8:08 PM
Immunome (Issuer)
Tsai Philip (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Collect $7k per month from Tesla’s SECRET dividend (Ad)

There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?

Click here to uncover Tesla's hidden income secret.
06/18/2024
7:48 PM
Barchas Isaac (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:05 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
3:49 PM
BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:13 PM
Immunome (Issuer)
SIEGALL CLAY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
4:11 PM
Immunome (Issuer)
Rosett Max (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
7:48 AM
Immunome (Filer)
Form 424B5
05/14/2024
7:05 AM
Immunome (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
7:02 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
7:14 PM
Immunome (Issuer)
SWAIN SANDRA M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
7:12 PM
Immunome (Issuer)
SWAIN SANDRA M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/26/2024
3:12 PM
Immunome (Filer)
Form ARS
04/25/2024
3:01 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2024
3:40 PM
Immunome (Filer)
Form S-3ASR
03/28/2024
3:04 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
3:06 PM
Immunome (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2024
7:05 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IMNM) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners